These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35646536)

  • 41. Long Noncoding RNA LINC00460 Promotes Cell Progression by Sponging miR-4443 in Head and Neck Squamous Cell Carcinoma.
    Li M; Zhang X; Ding X; Zheng Y; Du H; Li H; Ji H; Wang Z; Jiao P; Song X; Zhong Y; Wu H
    Cell Transplant; 2020; 29():963689720927405. PubMed ID: 32478564
    [TBL] [Abstract][Full Text] [Related]  

  • 42. PI3K Inhibitors Curtail MYC-Dependent Mutant p53 Gain-of-Function in Head and Neck Squamous Cell Carcinoma.
    Ganci F; Pulito C; Valsoni S; Sacconi A; Turco C; Vahabi M; Manciocco V; Mazza EMC; Meens J; Karamboulas C; Nichols AC; Covello R; Pellini R; Spriano G; Sanguineti G; Muti P; Bicciato S; Ailles L; Strano S; Fontemaggi G; Blandino G
    Clin Cancer Res; 2020 Jun; 26(12):2956-2971. PubMed ID: 31969334
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multi-Omics Identification of Genetic Alterations in Head and Neck Squamous Cell Carcinoma and Therapeutic Efficacy of HNC018 as a Novel Multi-Target Agent for c-MET/STAT3/AKT Signaling Axis.
    Khedkar HN; Chen LC; Kuo YC; Wu ATH; Huang HS
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373393
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Liberation of functional p53 by proteasome inhibition in human papilloma virus-positive head and neck squamous cell carcinoma cells promotes apoptosis and cell cycle arrest.
    Li C; Johnson DE
    Cell Cycle; 2013 Mar; 12(6):923-34. PubMed ID: 23421999
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Repositioning of the anthelmintic drug mebendazole for the treatment for colon cancer.
    Nygren P; Fryknäs M; Agerup B; Larsson R
    J Cancer Res Clin Oncol; 2013 Dec; 139(12):2133-40. PubMed ID: 24135855
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification and analysis of genes associated with head and neck squamous cell carcinoma by integrated bioinformatics methods.
    Jin Y; Yang Y
    Mol Genet Genomic Med; 2019 Aug; 7(8):e857. PubMed ID: 31304688
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of paclitaxel on permanent head and neck squamous cell carcinoma cell lines and identification of anti-apoptotic caspase 9b.
    Maushagen R; Reers S; Pfannerstill AC; Hahlbrock A; Stauber R; Rahmanzadeh R; Rades D; Pries R; Wollenberg B
    J Cancer Res Clin Oncol; 2016 Jun; 142(6):1261-71. PubMed ID: 27038158
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vitro effects of gamma-secretase inhibition in HPV-positive and HPV-negative head and neck squamous cell carcinoma.
    Varatanovic S; Maier T; Al-Gboore S; Stoiber S; Kandathil SA; Quint C; Brennus C; Heiduschka G; Kadletz-Wanke L; Brkic FF
    Invest New Drugs; 2023 Apr; 41(2):193-201. PubMed ID: 36809443
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A dual specificity kinase, DYRK1A, as a potential therapeutic target for head and neck squamous cell carcinoma.
    Radhakrishnan A; Nanjappa V; Raja R; Sathe G; Puttamallesh VN; Jain AP; Pinto SM; Balaji SA; Chavan S; Sahasrabuddhe NA; Mathur PP; Kumar MM; Prasad TS; Santosh V; Sukumar G; Califano JA; Rangarajan A; Sidransky D; Pandey A; Gowda H; Chatterjee A
    Sci Rep; 2016 Oct; 6():36132. PubMed ID: 27796319
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of radiation induced migration of human head and neck squamous cell carcinoma cells by blocking of EGF receptor pathways.
    Pickhard AC; Margraf J; Knopf A; Stark T; Piontek G; Beck C; Boulesteix AL; Scherer EQ; Pigorsch S; Schlegel J; Arnold W; Reiter R
    BMC Cancer; 2011 Sep; 11():388. PubMed ID: 21896192
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MiR-29c-3p/C1QTNF6 Restrains the Angiogenesis and Cell Proliferation, Migration and Invasion in Head and Neck Squamous Cell Carcinoma.
    Huang F; Qi H
    Mol Biotechnol; 2023 Jun; 65(6):913-921. PubMed ID: 36348139
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Circular RNA, hsa_circ_0018180 (circPARD3), Triggers Glycolysis and Promotes Malignancy of Head and Neck Squamous Cell Carcinoma Through the miR-5194/ENO1 Axis.
    Luo JT; Wang YF; Wang Y; Wang CL; Liu RY; Zhang Z
    Biochem Genet; 2023 Feb; 61(1):316-335. PubMed ID: 35900705
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Targeting of c-MET and AXL by cabozantinib is a potential therapeutic strategy for patients with head and neck cell carcinoma.
    Hagege A; Saada-Bouzid E; Ambrosetti D; Rastoin O; Boyer J; He X; Rousset J; Montemagno C; Doyen J; Pedeutour F; Parola J; Bourget I; Luciano F; Bozec A; Cao Y; Pagès G; Dufies M
    Cell Rep Med; 2022 Sep; 3(9):100659. PubMed ID: 36130479
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Establishment of anti-DKK3 peptide for the cancer control in head and neck squamous cell carcinoma (HNSCC).
    Katase N; Nishimatsu SI; Yamauchi A; Okano S; Fujita S
    Cancer Cell Int; 2022 Nov; 22(1):352. PubMed ID: 36376957
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structural insights into targeting of the colchicine binding site by ELR510444 and parbendazole to achieve rational drug design.
    Lei JH; Ma LL; Xian JH; Chen H; Zhou JJ; Chen H; Lei Q; Li YY; Wang YY; Wang YX
    RSC Adv; 2021 May; 11(31):18938-18944. PubMed ID: 35478655
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacological inhibition of CDK7 by THZ1 impairs tumor growth in p53-mutated HNSCC.
    Ge H; Yao Y; Jiang Y; Wu X; Wang Y
    Oral Dis; 2022 Apr; 28(3):611-620. PubMed ID: 33503275
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dihydroartemisinin as a Putative STAT3 Inhibitor, Suppresses the Growth of Head and Neck Squamous Cell Carcinoma by Targeting Jak2/STAT3 Signaling.
    Jia L; Song Q; Zhou C; Li X; Pi L; Ma X; Li H; Lu X; Shen Y
    PLoS One; 2016; 11(1):e0147157. PubMed ID: 26784960
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of four key prognostic genes and three potential drugs in human papillomavirus negative head and neck squamous cell carcinoma.
    Tian G; Fu Y; Zhang D; Li J; Zhang Z; Yang X
    Cancer Cell Int; 2021 Mar; 21(1):167. PubMed ID: 33712015
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tumor necrosis factor-α triggers opposing signals in head and neck squamous cell carcinoma and induces apoptosis via mitochondrial- and non-mitochondrial-dependent pathways.
    Selimovic D; Wahl RU; Ruiz E; Aslam R; Flanagan TW; Hassan SY; Santourlidis S; Haikel Y; Friedlander P; Megahed M; Kandil E; Hassan M
    Int J Oncol; 2019 Dec; 55(6):1324-1338. PubMed ID: 31638203
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Involvement of the Wnt/β-Catenin signaling pathway in the heterogenous nuclear ribonucleoprotein K-driven inhibition of proliferation and migration in head and neck squamous cell carcinoma.
    Liu H; Chen X; Yang X; Li M; Zhang W; Zhang G; Zhan X; Cao L; Li W; Huang Z; Gao R
    Oncol Lett; 2020 Dec; 20(6):394. PubMed ID: 33193854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.